Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis

NCT01442779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Tract Diseases
Lung Diseases
Lung Diseases, Interstitial
Pulmonary Fibrosis

Interventions

DRUG: Interferon alpha oral lozenge

Sponsor

Texas Tech University Health Sciences Center

Collaborators

[object Object]